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Infective endocarditis (IE) is the proliferation of micro-
organisms on the endocardium of the heart. Endocar-
ditis caused by Mycobacterium abscessus (M. abscessus)
is rare and only five cases have been published since
1975. Four of the five patients with M. abscessus endo-
carditis were associated with prosthetic valve infec-
tion. Only one patient with native valve endocarditis
caused by M. abscessus has been published [1]. 
M. abscessus endocarditis has been found to be associ-
ated with history of surgery (cardiac, valvular), foreign
bodies, trauma, intravenous (IV) injections, hemodial-
ysis or immunocompromised status. Here, we present
a case of native valve endocarditis with M. abscessus
infection.
CASE PRESENTATION
A 29-year-old male patient who was an IV heroin
abuser had an episode of methicillin susceptible
Staphylococcus aureus (MSSA)-associated tricuspid
valve infective endocarditis that was previously
treated once in January 2006. Mild tricuspid regurgi-
tation (TR) and vegetation (0.6×0.9 cm) were involved
in the septal leaflet of the tricuspid valve as deter-
mined by echocardiography. In June 2006, he was
readmitted with a fever extending for 1 month. Vege-
tation (0.75×1.66cm) with high echogenicity involving
the septal leaflet of the tricuspid valve and moderate
TR was found by echocardiography. A smear from cul-
ture medium of blood culture (BACTEC system, SA
bottle) showed acid-fast stain (AFS)-positive bacilli.
He was treated for miliary tuberculosis (TB) initially
with rifampin 600 mg/day and isoniazid 300 mg/day,
ethambutol 800 mg/day, pyrazinamide 1,500 mg/day
plus streptomycin 1 g/day, and he was discharged in
July 2006 with afebrile status. He continued with oral
Received: Dec 21, 2007 Accepted: Apr 17, 2008
Address correspondence and reprint requests to:
Dr Wen-Ter Lai, Division of Cardiology, Depart-
ment of Internal Medicine, Kaohsiung Medical
University Hospital, 100 Tzyou 1st Road,
Kaohsiung 807, Taiwan.
E-mail: wtlai@cc.kmu.edu.tw
MYCOBACTERIUM ABSCESSUS ENDOCARDITIS: 
A CASE REPORT AND LITERATURE REVIEW
Wei-Chung Tsai,1,2 Hsiao-Cheng Hsieh,3 Ho-Ming Su,1 Po-Liang Lu,2 Tsung-Hsien Lin,1,2
Sheng-Hsiung Sheu,1,2 and Wen-Ter Lai1,2
1Division of Cardiology, Department of Internal Medicine, Kaohsiung Medical University Hospital,
2Department of Internal Medicine, Faculty of Medicine, College of Medicine, Kaohsiung Medical 
University, and 3Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, 
Kaohsiung, Taiwan.
Infective endocarditis owing to Mycobacterium abscessus infection is rarely reported. Most cases of
infective endocarditis caused by Mycobacterium abscessus are seen in patients after valve replace-
ment. Although early surgical intervention is recommended and medical treatment with antibi-
otics according to the susceptibility to the pathogen, such as amikacin, imipenem, cefoxitin,
quinolones and macrolides, are applied, the course of such endocarditis is usually subacute and
often has fatal outcomes. The present case was a 29-year-old male patient who was an intra-
venous drug user who had recurrent endocarditis caused by Mycobacterium abscessus. Unusually,
our reported case was infected on his native valve. However, we experienced recurrence despite
antimicrobial therapy. For culture-negative endocarditis, physicians should consider the possibility
of Mycobacterium abscessus infection and related treatment difficulties.
Key Words: endocarditis, Mycobacterium abscessus
(Kaohsiung J Med Sci 2008;24:481–6)
Kaohsiung J Med Sci September 2008 • Vol 24 • No 9482
W.C. Tsai, H.C. Hsieh, H.M. Su, et al
rifampin 600 mg/day and isoniazid 300 mg/day,
ethambutol 800 mg/day and pyrazinamide 1,500 mg/
day after discharge.
In August 2006, he was admitted again with
relapse of the fever. The blood culture obtained at the
patient’s hospitalization in June 2006 was identified
to be M. abscessus according to a polymerase chain
reaction (PCR)-restriction fragment length polymor-
phism (RFLP) analysis of the 65-kDa heat shock 
protein (Figure 1) [2]. Echocardiography revealed a
2.3 × 1.9 cm vegetation over the septal leaflet of the
tricuspid valve and severe TR. The vegetation was
bigger than that recorded during the previous echo-
cardiogram in June 2006. In response to the presence
of M. abscessus in the blood culture, he started treat-
ment with clarithromycin 500 mg/day and imipenem
250 mg twice daily for 4 weeks. He was discharged
with afebrile status and was free from heart failure.
Echocardiography before discharge revealed that the
vegetation size had decreased to 1.73 × 1.69 cm. He
continued with oral clarithromycin 500 mg/day plus
moxifloxacin 400 mg/day treatment until November
2006.
In November 2006, he was readmitted for recur-
rent infective endocarditis. Echocardiography revealed
severe TR with two vegetations (0.72 × 1.06 cm; 2.41 ×
1.04 cm) over the septal and anterior leaflets of the
tricuspid valve (Figures 2A and 2B). Chest X-ray re-
vealed pneumonia over the right middle lung field.
Initial laboratory data revealed: white blood cell count
(WBC) 7,730/μL; hemoglobin 10.1 g/dL; platelets
120,000/μL; blood urea nitrogen 35.6mg/dL; creatinine
2.04 mg/d; and C-reactive protein (CRP) 104 mg/L.
Blood culture still showed AFS-positive bacilli but neg-
ative findings for common aerobic pathogens. Because
of suspected TB-associated IE, he was treated with
rifampin 600 mg/day and isoniazid 300 mg/day, eth-
ambutol 800mg/day plus clarithromycin 500mg twice
daily. Surgical intervention was strongly suggested,
but the patient hesitated and finally received contin-
ued medical therapy. Chest computed tomography
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Figure 1. PCR-RFLP for isolates of M. abscessus. The restriction
enzyme used to generate the PCR-RFLP pattern for each lane is
indicated. Lane M = molecular size marker (50-bp ladder).
A B
Figure 2. Echocardiography: parasternal short axis view. Two vegetations are shown. (A) Vegetation A (0.72 × 1.06 cm) was observed
at the septal leaflet of the tricuspid valve (arrowhead). (B) Vegetation B (2.41 × 1.04 cm) was observed at the anterior leaflets of the 
tricuspid valve (arrow). The echogenicity of the vegetation is high compared with the adjacent heart tissue.
demonstrated TB pneumonia-like lesions in the right
lower and middle lung with right pleural effusion and
pericardial effusion. Blood cultures still produced 
M. abscessus. A sputum smear revealed AFS-positive
bacilli and sputum culture grew M. abscessus. Since
the M. abscessus endocarditis relapsed after imipenem,
clarithromycin and moxifloxacin treatment, clar-
ithromycin plus amikacin were chosen as the treat-
ment regimen. After treatment with clarithromycin
500 mg twice daily plus amikacin 750 mg/day for 
2 weeks, he became afebrile and vital signs stabilized.
There were no signs of heart failure. The pneumonia-
like lesions improved after antibiotic treatment, and
laboratory data before discharge were: CRP 73 mg/L
(normal range, <5 mg/L); and WBC 6,670/μL. He was
discharged with continuing oral clarithromycin 500mg
twice daily plus ciprofloxacin 400 mg twice daily for
8 weeks at our clinic, and was then lost to follow-up.
At his last visit to our clinic in January 2007, we
repeated the echocardiography. It revealed that the
size of the vegetations had decreased to 0.8 × 1.5 cm
and 2.2 × 1.1 cm over the septal and anterior leaflets
of the tricuspid valve, respectively, and the TR was
still severe. The patient had poor medication compli-
ance and “doctor shopping” between hospitals. Even
though we planned for him to receive surgical inter-
vention and a full course of antibiotic treatment, he
hesitated and was subsequently lost to follow-up and
did not receive further management from us. The
patient had positive rheumatoid factor, decreased com-
plement level (C3, 28.1 mg/dL; C4, 9.25 mg/dL) and
decreased CD4 count (155/mm3), but was negative
for human immunodeficiency virus antibody and
negative for antinuclear antibodies.
DISCUSSION
Infective endocarditis caused by M. abscessus is very
rare and unique; accordingly, we have reviewed the
literature about the care and prognosis of this dis-
ease. M. abscessus is grouped with a number of rapid-
growth nontuberculous mycobacteria (NTM), which
includes M. fortuitum, M. chelonae, and M. abscessus.
These rapid-growth NTM have been found in potable
and natural water, and in soil. They can also be iso-
lated from contaminated tap water. Infection with 
M. abscessus may lead to localized infections such as
subcutaneous abscesses, lymphadenitis, pneumonia,
keratitis, prosthetic valve endocarditis, osteomyelitis,
meningitis and disseminated infection [3–5]. The 
pulmonary lesion and the endocarditis caused by 
M. abscessus in this case were identified based on the
PCR-RFLP study of the gene encoding for the 65-kDa
heat shock protein [2].
To our knowledge, only one other case has been
reported in the literature to have native valve endo-
carditis caused by M. abscessus [1]. In a review of the
English-language publications, endocarditis caused by
M. chelonae (formerly M. chelonae subspecies chelonae)
or M. abscessus (formerly M. chelonae subspecies
abscessus) has been documented in only nine cases.
Since M. abscessus has also been classified as M. che-
lonae before, we reviewed endocarditis with the search
terms of M. chelonae and M. abscessus but not of 
M. fortuitum. Five of the nine cases were infected with
M. abscessus and the others were infected by M. che-
lonae. Seven of them were associated with prosthetic
valve endocarditis, but none of them survived after
treatment. The only surviving case was associated
with native valve endocarditis [1,3,5–10]. Most of the
cases infected with NTM endocarditis were subacute
and had fatal outcomes, especially those with pros-
thetic valve endocarditis (Table). Infective endocarditis
owing to NTM infection was considered when asso-
ciated with the status after valvular and cardiac sur-
gery, immunocompromised hosts, intravenous drug
abuse, dialysis, patients who received renal transplant
and immunosuppressive therapy, and individuals on
corticosteroid therapy [3,5,6,9].
The case we reported is only the second patient to
have native valve endocarditis infected by M. abscessus.
The portal of entry in our case was not clear, but may
be attributed to his use of tap water for heroin pow-
der dilution and for injection. Another contributing
factor was his immune system compromise with low
complement, low CD4 level and positive rheumatoid
factor, which may be related to his drug abuse,
although the decreased complement level and posi-
tive rheumatoid factor may be the result of IE.
Rapid-growth NTM has been reported to be re-
sistant to many antimicrobial agents, including most
primary and secondary line antituberculosis agents
in vitro. However, some strains of M. abscessus and
M. chelonae were found to be sensitive to amikacin,
clarithromycin, cefoxitin, erythromycin and quinolone
[3,10]. Combination therapy with different classes of
antimicrobial agents is usually recommended because
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monotherapy was found to cause resistance of NTM
[11]. The duration of antimicrobial therapy in patients
with NTM-related endocarditis is still controversial.
Previous reports have suggested that the antimicro-
bial treatment should last for at least 6 months or 
3 months after aggressive surgical intervention [3].
Owing to frequent failure of medical treatment, early
surgical intervention in combination with antimicro-
bial treatment has been recommended for patients
with NTM-related endocarditis [3,4,9,10]. Our case
was treated with clarithromycin plus amikacin, and
antimicrobial therapy was shifted to the oral form of
ciprofloxacin plus clarithromycin for 8 weeks after
discharge. It is not clear whether the exacerbation 
of IE could be restrained by clarithromycin plus
ciprofloxacin treatment because the patient in our
case study was treated for only 8 weeks and then lost
to follow-up.
In summary, infective endocarditis caused by 
M. abscessus and other rapid-growth mycobacterium
is not readily diagnosed and treated. For culture-
negative endocarditis, awareness of the possibility of
NTM infection should be considered, especially when
patients have related predisposing factors.
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膿腫分枝桿菌心內膜炎 — 病例報告與文獻探討
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膿腫分枝桿菌 (Mycobacterium abscessus) 引起的感染性心內膜炎是非常罕見的。
大部分膿腫分枝桿菌引起的感染性心內膜炎是發生在瓣膜置換術後之瓣膜。儘管應用
了早期手術介入及根據敏感性測驗使用抗生素如 amikacin，imipenem，
cefoxitin，quinolone，macrolides 的治療，此種心內膜炎仍然是亞急性且致命
的。我們發表一個 29 歲的靜脈毒癮者其感染上由膿腫分枝桿菌引起的復發性心內
膜。我們報告的病例非常罕見的在其自然瓣膜上受到膿腫分枝桿菌的感染而引起心內
膜炎，儘管在抗生素治療後其仍復發。對於血培養陰性的感染性心內膜炎，醫師必須
要考慮到膿腫分枝桿菌感染的可能性和其治療上的困難性。
關鍵詞：心內膜炎，膿腫分枝桿菌
(高雄醫誌 2008;24:481–6)
